CANO HEALTH INC (CANO) Stock Analyst Earnings Estimates
NYSE:CANO - New York Stock Exchange, Inc. - US13781Y2028 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 831.6M 130.11% | 1.609B 93.53% | 2.739B 70.18% | 3.2B 16.84% | 2.847B -11.03% | 2.959B 3.93% | 2.996B 1.25% | 3.06B 2.14% | 3.118B 1.90% | 3.175B 1.83% | 3.23B 1.73% | |
| EBITDA YoY % growth | 18.3M 735.42% | -85.76M -568.63% | -18.16M 78.82% | -251.083M -1,282.61% | -10.2M 95.94% | 90.772M 989.92% | 175.44M 93.28% | 236.64M 34.88% | 257.04M 8.62% | 278.46M 8.33% | 300.9M 8.06% | |
| EBIT YoY % growth | -200K 97.94% | -135.2M -67,500.00% | -108.8M 19.53% | -465.12M -327.50% | -53.683M 88.46% | 18.737M 134.90% | 108.12M 477.04% | 171.36M 58.49% | 189.72M 10.71% | 209.1M 10.22% | 228.48M 9.27% | |
| Operating Margin | -0.02% | -8.40% | -3.97% | -14.54% | -1.89% | 0.63% | 3.61% | 5.60% | 6.08% | 6.59% | 7.07% | |
| EPS YoY % growth | N/A | N/A | 12.90 220.45% | -165.61 -1,383.78% | -38.06 77.02% | -17.77 53.32% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -18.30 -146.92% | -13.33 -11.10% | -8.48 83.37% | -11.21 87.79% | -6.28 65.66% | -6.07 54.48% | -6.25 26.28% | -4.41 60.71% | -5.11 18.67% |
| Revenue Q2Q % growth | 735.36M 8.08% | 755.15M -12.89% | 706.31M -7.88% | 726.1M -7.87% | 707.6M -3.78% | 800.42M 5.99% | 720.76M 2.05% | 767.47M 5.70% | 697.69M -1.40% |
| EBITDA Q2Q % growth | -39.44M -177.27% | -6.712M 45.35% | -7.752M 95.94% | 10.96M 134.59% | 14.239M 136.10% | 19.237M 386.62% | 15.157M 295.52% | 25.102M 129.03% | 18.972M 33.24% |
| EBIT Q2Q % growth | -57.35M -44.82% | -24.449M 38.10% | -3.29M 98.66% | -20.155M 82.15% | -5.681M 90.09% | -775.2K 96.83% | -2.856M 13.18% | 5.916M 129.35% | 1.53M 126.93% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -91.87 -299.43% | -18.78 | -73.09 | -389.24% |
| Q2 2023 Q2Q % growth | -51.00 -1,600.00% | -11.99 | -39.02 | -325.53% |
| Q1 2023 Q2Q % growth | -12.00 -11,900.00% | -12.43 | 0.43 | 3.48% |
| Q4 2022 Q2Q % growth | 39.00 | -12.89 | 51.89 | 402.66% |
| Q3 2022 Q2Q % growth | -23.00 -25,455.56% | -4.84 | -18.16 | -375.42% |
| Q2 2022 Q2Q % growth | -3.00 -30,100.00% | -5.47 | 2.47 | 45.20% |
| Q1 2022 Q2Q % growth | -0.10 | -6.70 | 6.60 | 98.51% |
| Q4 2021 Q2Q % growth | 0.00 | -0.02 | 0.02 | 100.00% |
| Q3 2021 Q2Q % growth | -0.09 | -0.01 | -0.08 | -1,197.58% |
| Q2 2021 Q2Q % growth | 0.01 | -0.01 | 0.02 | 198.04% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 788.1M 18.51% | 786.42M | 1.68M | 0.21% |
| Q2 2023 Q2Q % growth | 766.7M 11.21% | 845M | -78.3M | -9.27% |
| Q1 2023 Q2Q % growth | 866.9M 23.09% | 823.25M | 43.65M | 5.30% |
| Q4 2022 Q2Q % growth | 680.4M 66.24% | 667.62M | 12.78M | 1.91% |
| Q3 2022 Q2Q % growth | 665M 33.29% | 732.29M | -67.29M | -9.19% |
| Q2 2022 Q2Q % growth | 689.4M 100.64% | 726.87M | -37.47M | -5.15% |
| Q1 2022 Q2Q % growth | 704.3M 156.48% | 668.6M | 35.7M | 5.34% |
| Q4 2021 Q2Q % growth | 409.3M | 542.28M | -132.98M | -24.52% |
| Q3 2021 Q2Q % growth | 498.9M | 456.59M | 42.31M | 9.27% |
| Q2 2021 Q2Q % growth | 343.6M | 312.99M | 30.61M | 9.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.5% | 0% | -15217% |
| Revenue | -0.06% | -0.37% | -0.19% | 0.5% |